New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|July 1, 2002
Supplements and Featured Publications
- Symposium Reporter: Reaching Goal - Conquering the Treatment Gaps in Dyslipidemia
- Volume 8
- Issue 2 Symp
Role of hs-CRP in Cardiovascular Risk Prediction
Author(s)Paul M. Ridker, MD, MPH
Advertisement
Articles in this issue
about 24 years ago
Statin Pharmacology May Have Important Clinical Implicationsabout 24 years ago
Changes in ATP III focus on diabetes and the metabolic syndromeabout 24 years ago
Role of managed care in implementing NCEP-ATP III guidelinesabout 24 years ago
Aggressive Lipid Reduction Provides Additional Clinical BenefitAdvertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Roundtables reveal HFpEF/HFmrEF care lags despite rising cases; learn new SGLT2/MRA strategies, screening, and scalable team pathways.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Treatment for Sanfilippo Syndrome Type A
2
No Blood Biomarker Is Ready to Pick Psoriasis Therapy
3
Regorafenib Prescribing in Advanced GIST Deviates From Guidelines
4
Oral GLP-1s, Medicare Bridge Reshape Obesity Care: Holly Lofton, MD
5